Ceftaroline Fosamil Injection, Powder, Lyophilized, For Solution
Product Images NDC 60505-4946

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Ceftaroline Fosamil (NDC 60505-4946). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton-label-400mg-10s-antibiotic.jpg (Carton Label 400mg 10s Antibiotic)

Packaging label for Ceftaroline Fosamil for Injection 400 mg/vial, a lyophilized powder for intravenous infusion. The label states the product is for intravenous infusion only and includes 10 single-dose vials per package. It indicates the drug must be diluted before intravenous infusion and is manufactured by Apotex Corp. with additional manufacturing by QILU Antibiotics Pharmaceutical Co., Ltd. Storage and constitution instructions are provided on the label.*

FDA Label Image

Carton-label-400mg-10s.jpg (Carton Label 400mg 10s)

Ceftaroline Fosamil for Injection 400 mg/vial powder, lyophilized for solution, designed for intravenous infusion. The label states 10 single-dose vials with instructions to further dilute the solution before infusion. Manufactured by Qilu Pharmaceutical Co., Ltd., labeled for Apotex Corp. The packaging includes dosage, storage information, and a barcode.*

FDA Label Image

Carton-label-600mg-10s-antibiotic.jpg (Carton Label 600mg 10s Antibiotic)

Packaging label for Ceftaroline Fosamil for Injection 600 mg/vial. The label indicates it is for intravenous infusion only and contains 10 single-dose vials. It notes that the constituted solution must be further diluted for intravenous infusion. The label lists Apotex Corp. as the manufacturer and includes dosage and storage instructions. The label features a barcode and trademark information for PremierProRx.*

FDA Label Image

Carton-label-600mg-10s.jpg (Carton Label 600mg 10s)

Ceftaroline Fosamil for Injection 600 mg/vial powder, lyophilized, for intravenous infusion. The package contains 10 single-dose vials. Labeler is Apotex Corp. The label provides dosage form, strength, route, storage instructions, and detailed reconstitution and dilution information. The label also shows the NDC 60505-4947-0 and manufacturer QiLu Pharmaceutical Co., Ltd.*

FDA Label Image

Structure (Structure)

Chemical structure of Ceftaroline Fosamil, showing its molecular arrangement including rings, phosphate group, and other characteristic chemical bonds.*

FDA Label Image

Vial-label-400mg-antibiotic.jpg (Vial Label 400mg Antibiotic)

The label for Ceftaroline Fosamil for Injection, 400 mg per vial, lyophilized powder for intravenous infusion. It is a single-dose vial labeled for intravenous use only and is manufactured by Apotex Corp. The label includes dilution instructions, storage conditions, and registration information for PREMIERProRx.*

FDA Label Image

Vial-label-400mg.jpg (Vial Label 400mg)

Ceftaroline Fosamil for Injection 400 mg/20 mL lyophilized powder for solution, indicated for intravenous infusion. Single-dose vial with instructions for diluent and storage. Labeler is Apotex Corp., with manufacturing by QILU Pharmaceutical Co., Ltd. The label includes NDC 60505-4946-1 and usage details for preparation and storage.*

FDA Label Image

Vial-label-600mg-antibiotic.jpg (Vial Label 600mg Antibiotic)

Ceftaroline Fosamil 600 mg/vial injection powder for solution label. The vial is single-dose for intravenous infusion only, with instructions to discard after use. The label includes preparation details, storage instructions, and manufacturer information: QILU Antibiotics Pharmaceutical Co., Ltd., with Apotex Corp. as the labeler. Premier ProRx branding is present on the label.*

FDA Label Image

Vial-label-600mg.jpg (Vial Label 600mg)

Ceftaroline Fosamil 600 mg/vial injection powder for solution, lyophilized form. The label specifies intravenous administration, single-dose vial, with instructions to discard after use. It is labeled by Apotex Corp. and includes NDC 60505-4947-1.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.